October 8, 2025 · Form 4 insider transaction
Arif Bilal bought 100,000 shares of KalVista Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
The option vests over a 4-year period: 25% vests on October 8, 2026, after which 1/48th of the total shares vest monthly, subject to reporting person's continued service through each vesting date.